Nigeria's and indeed Africa’s health systems are over dependent on international markets. Up to 70% of pharmaceutical products are imported. Local vaccine production capacities address less than 1% of the local demand in value. The COVID-19 pandemic has shown that African countries need to beco
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp